Stearidonic-Enriched Soybean Oil Modulates Obesity, Glucose Metabolism, and Fatty Acid Profiles Independently of Akkermansia muciniphila

Authors

Rafael R. Segura Munoz, University of Nebraska-Lincoln
Truyen Quach, University of Nebraska-Lincoln
João C. Gomes-Neto, University of Nebraska-Lincoln
Yibo Xian, University of Nebraska-Lincoln
Pamela A. Pena, University of Nebraska-Lincoln
Steven Weier, University of Nebraska-Lincoln
Michael A. Pellizzon, Research Diets, Inc.
Hatem Kittana, University of Nebraska-Lincoln
Liz A. Cody, University of Nebraska-Lincoln
Abby L. Geis, University of Nebraska-Lincoln
Kari Heck, University of Nebraska-Lincoln
Robert J. Schmaltz, University of Nebraska-Lincoln
Laure B. Bindels, University of Nebraska-Lincoln
Edgar B. Cahoon, University of Nebraska-Lincoln
Andrew K. Benson, University of Nebraska-Lincoln
Tom Elmo Clemente, University of Nebraska-Lincoln
Amanda E. Ramer-Tait, University of Nebraska-LincolnFollow

Date of this Version

2020

Citation

Mol Nutr Food Res. 2020 September ; 64(17): e2000162. doi:10.1002/mnfr.202000162.

Comments

Author manuscript Mol Nutr Food Res. Author manuscript; available in PMC 2021 November 21.

Abstract

Scope: Previous studies have suggested that diets rich in omega-3 and low in omega-6 long- longchain polyunsaturated fatty acids (PUFAs) can limit the development of metabolic syndrome (MetS). Transgenic soybeans yielding oils enriched for omega-3 PUFAs represent a new and readily-available option for incorporating omega-3 PUFAs into diets to provide health benefits. Methods and Results: Transgenic soybean oils, enriched for either stearidonic acid (SDA) or eicosapentaenoic acid (EPA), are incorporated into diets to test their effects on limiting the development of MetS in a mouse model of diet-induced obesity. Supplementation with SDA- but not EPA-enriched oils improved features of MetS compared to feeding a control wild-type oil. Because previous studies have linked the gut microorganism Akkermansia muciniphila to the metabolic effects of feeding omega-3 PUFAs, the causal contribution of A. muciniphila to mediating the metabolic benefits provided by SDA-enriched diets is investigated. Although A. muciniphila is not required for SDA-induced metabolic improvements, this microorganism does modulate levels of saturated and mono-unsaturated fatty acids in host adipose tissues. Conclusion: Together, these findings support the utilization of SDA-enriched diets to modulate weight gain, glucose metabolism, and fatty acid profiles of liver and adipose tissue.